[Aldehyde dehydrogenase 2(ALDH2) gene polymorphism in NIDDM patients with chronic renal failure]. 1998

S Kuriyama, and Y Suzuki, and Y Atsumi, and H Tomonari, and K Matsuoka, and T Houjou, and R Shoji, and T Hosoya
Division of Nephrology, Diabetes Research Center, Saiseikai Central Hospital, Tokyo, Japan.

In order to investigate the influence of aldehyde dehydrogenase 2(ALDH2) genotype in the pathogenesis of nephropathy due to non-insulin dependent diabetes mellitus (NIDDM), genotyping of ALDH2 was measured using the PCR-RFLP method in patients with NIDDM on chronic hemodialysis (HD). The results were as follows; 1) The frequency of active ALDH2 was 63% and that of inactive ALDH2 was 37%. 2) The percentage of active ALDH2 was significantly higher in patients with alcohol tolerance than that in those without it (38%). 3) The estimated amount of alcohol consumption in the past was 506 +/- 720 g/week in the active ALDH2 group, and 156 +/- 288 g/week in the inactive ALDH2 group, showing a significant difference between the two groups. 4) Interdialytic body weight gain was larger in patients with active ALDH2 than in those with inactive ALDH2. Since the frequency of active ALDH2 was similar to that in patients without nephropathy, these results do not support the hypothesis that ALDH2 gene polymorphism is involved in the development and persistence of chronic renal failure due to NIDDM. However, salt and water craving in dialysis patients may be influenced partially by an active ALDH2 gene.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011110 Polymorphism, Genetic The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level. Gene Polymorphism,Genetic Polymorphism,Polymorphism (Genetics),Genetic Polymorphisms,Gene Polymorphisms,Polymorphism, Gene,Polymorphisms (Genetics),Polymorphisms, Gene,Polymorphisms, Genetic
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000071396 Aldehyde Dehydrogenase, Mitochondrial An aldehyde dehydrogenase expressed in the mitochondrial matrix that is essential for the metabolism of ETHANOL. ALDH2 Protein,Dehydrogenase, Mitochondrial Aldehyde,Mitochondrial Aldehyde Dehydrogenase
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000428 Alcohol Drinking Behaviors associated with the ingesting of ALCOHOLIC BEVERAGES, including social drinking. Alcohol Consumption,Alcohol Intake,Drinking, Alcohol,Alcohol Drinking Habits,Alcohol Drinking Habit,Alcohol Intakes,Consumption, Alcohol,Drinking Habit, Alcohol,Habit, Alcohol Drinking,Habits, Alcohol Drinking,Intake, Alcohol

Related Publications

S Kuriyama, and Y Suzuki, and Y Atsumi, and H Tomonari, and K Matsuoka, and T Houjou, and R Shoji, and T Hosoya
January 2010, Neuroscience letters,
S Kuriyama, and Y Suzuki, and Y Atsumi, and H Tomonari, and K Matsuoka, and T Houjou, and R Shoji, and T Hosoya
March 2004, Yi chuan = Hereditas,
S Kuriyama, and Y Suzuki, and Y Atsumi, and H Tomonari, and K Matsuoka, and T Houjou, and R Shoji, and T Hosoya
January 2016, Nihon eiseigaku zasshi. Japanese journal of hygiene,
S Kuriyama, and Y Suzuki, and Y Atsumi, and H Tomonari, and K Matsuoka, and T Houjou, and R Shoji, and T Hosoya
December 2015, Genetics and molecular research : GMR,
S Kuriyama, and Y Suzuki, and Y Atsumi, and H Tomonari, and K Matsuoka, and T Houjou, and R Shoji, and T Hosoya
April 2017, Respiratory research,
S Kuriyama, and Y Suzuki, and Y Atsumi, and H Tomonari, and K Matsuoka, and T Houjou, and R Shoji, and T Hosoya
January 2012, Ethnicity & disease,
S Kuriyama, and Y Suzuki, and Y Atsumi, and H Tomonari, and K Matsuoka, and T Houjou, and R Shoji, and T Hosoya
June 2005, Biochemical genetics,
S Kuriyama, and Y Suzuki, and Y Atsumi, and H Tomonari, and K Matsuoka, and T Houjou, and R Shoji, and T Hosoya
January 2015, International journal of clinical and experimental medicine,
S Kuriyama, and Y Suzuki, and Y Atsumi, and H Tomonari, and K Matsuoka, and T Houjou, and R Shoji, and T Hosoya
November 2009, Toxicology mechanisms and methods,
S Kuriyama, and Y Suzuki, and Y Atsumi, and H Tomonari, and K Matsuoka, and T Houjou, and R Shoji, and T Hosoya
November 1988, American journal of human genetics,
Copied contents to your clipboard!